Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma.
Walker JS, Wenzl K, Novak JP, Stokes ME, Hopper MA, Dropik AR, Siminski MS, Bock AM, Sarangi V, Ortiz M, Stong N, Huang CC, Maurer MJ, Link BK, Ansell SM, Habermann TM, Witzig TE, King RL, Nowakowski G, Cerhan JR, Gandhi AK, Novak AJ.
Walker JS, et al.
Blood Cancer J. 2025 Jul 12;15(1):120. doi: 10.1038/s41408-025-01326-5.
Blood Cancer J. 2025.
PMID: 40651974
Free PMC article.